FOR IMMEDIATE RELEASE JULY 18TH 2018
Vancouver, British Columbia, Canada – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company has signed an e-commerce and technology services agreement (the “Agreement”) with BlissCo Cannabis Corp Inc. (“BlissCo”) (CNSX: BLIS) (FRA: GQ4B:GR), whereby Namaste will provide services including access to Namaste’s technology platforms, software integrations and e-commerce services including those powered by Namaste’s e-commerce artificial intelligence (AI) platform, Findify.io.
Under the terms of this Agreement, Namaste will leverage its proprietary technology platforms to develop an innovative online marketplace in partnership with BlissCo to enhance BlissCo’s patient experience. BlissCo is a Canadian licensed producer and distributor of high-quality medical cannabis that operates an Access to Cannabis for Medical Purposes Regulations (“ACMPR”) cultivation facility based in Langley, BC.
Namaste has developed industry-leading technology platforms which bring significant value to both the Company and the cannabis industry. This Agreement with BlissCo represents Namaste’s ability to enhance the consumer experience for its own customers and those of its industry peers.
Under the terms of the Agreement, Namaste will assist BlissCo in enhancing its online platform by utilizing Namaste’s suite of innovative technologies including;
- A comprehensive audit of BlissCo e-commerce platform.
- Enhancement recommendations to improve user experience.
- Software integrations including AI and machine learning through Findify.io.
- Customization of Namaste’s telemedicine application, NamasteMD.
- E-commerce development services including programming and IT.
- Access to same-day delivery service through Pineapple Express Inc.
Blissco will compensate Namaste for services with 210,000 common stock options with a strike price at $0.32 for a three-year term.
Namaste is also pleased to announce that President and CEO, Sean Dollinger will join BlissCo’s board of directors. Namaste believes support from its management team will bring value to BlissCo’s board in areas of technology and e-commerce.
Each option will have an exercise term of up to three (3) years and vesting will be determined by management.
Namaste is focused on development and acquisition of innovative technologies that will have a significant impact on the cannabis industry. As legalization of medical and recreational cannabis evolves globally and cannabis prices consolidate, Namaste will focus on technology and e-commerce innovations that can offer significant value to the Company and its industry peers. As many companies focus on cultivation, Namaste is establishing its position as a leader in e-commerce and technology in the cannabis industry.
Damian Kettlewell, President and CEO of Blissco comments; “By signing this partnership with Namaste, we are able to offer our patients direct access to BlissCo products. This direct connection to the customer will provide the BlissCo Ecosystem with a critical feedback loop to continuously improve our offerings and focus attention on what the end users are looking for. Further, a great customer experience is paramount for us and this technology gives us the tools we need to deliver that seamlessly.”
We’re also very pleased to have Namaste’s CEO Sean Dollinger join our board of directors and feel that Sean will bring great value and insight to our board and we look forward to expanding our relationship with Namaste in the future.
Sean Dollinger, President and CEO of Namaste comments; “We’re very proud to be partnering with Blissco and offering these services. We truly feel that the technology we’re developing will bring great value to others as well. We consider ourselves very fortunate to be breaking ground in exciting areas of technology including AI and machine learning within applications in the cannabis industry. Our technology platforms, like NamasteMD can also help all Canadian with more convenient access to medical cannabis from the comfort of their home. We’re proud to be able to offer these platforms to partners and enhance their patient’s consultation and buying experience. We’re certainly looking forward to working with Blissco and their team who we believe are aligned with Namaste’s values and have great respect for their management team. Namaste will continue to create and acquire innovative technologies both domestically and abroad.”
About BlissCo Cannabis Corp.
BlissCo Cannabis Corp. (CSE: BLIS) (FRA: GQ4B) is an ACMPR licensed producer and future distributor of ultra-premium cannabis. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships.
BlissCo leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.
BlissCo is backed by an experienced team that is deeply in tune and integrated with industry partners and BlissCo’s future patients and customers.
About Namaste Technologies Inc.
Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste’s product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and the company will soon be selling medical cannabis in the Canadian market, subject to approval by Health Canada.
Namaste has developed and acquired innovative technology platforms including NamasteMD.com, Canada’s first Health Canada compliant telemedicine application, and in May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB. Findify uses artificial intelligence algorithms to optimize and personalize a consumer’s on-site buying experience. Namaste is focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.
On behalf of the Board of Directors
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]
Further information on the Company and its products can be accessed through the links below:
FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press